15 results
8-K
EX-1.1
CGTX
Cognition Therapeutics Inc
14 Nov 22
Cognition Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update
8:00am
, it shall be deemed to be followed by the words “without limitation”;
(e) references herein to any gender shall include each other gender;
(f
DEF 14A
t7k566er7955 fhij5u
25 Apr 22
Definitive proxy
5:28pm
424B4
bvm0 v0850mj
12 Oct 21
Prospectus supplement with pricing info
4:11pm
S-1
EX-10.4
dxrmn8tfbm6698c7cy
19 Jul 21
IPO registration
7:02am
S-1
k3jix5elslhr5d
19 Jul 21
IPO registration
7:02am
DRS/A
5pk67g
23 Jun 21
Draft registration statement (amended)
12:00am
DRS
EX-10.4
0f6wocnf
7 May 21
Draft registration statement
12:00am
DRS
n5l29v33dj8
7 May 21
Draft registration statement
12:00am
- Prev
- 1
- Next